A 34-year-old cisgender woman is seen in a walk-in clinic for evaluation of vaginal discharge, itching, and discomfort. She has one regular, long-term sex partner, a cisgender man. She is diagnosed with bacterial vaginosis, and she prefers not to take an oral antibiotic. She is prescribed a 3-day course of intravaginal clindamycin ovules.
What is the major concern regarding the use of intravaginal clindamycin ovules as a treatment for bacterial vaginosis?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
March 25th, 2022
March 25th, 2022
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME+MOC
4
Give Feedback
Complete survey
5